2001 Compliance Public Health World Health 
SQA
APRIL 30, 2021
In addition, considering the fact that one marketing authorization application is submitted in accordance with Article 8(3) of Directive 2001/83/EC and the other marketing authorization application is submitted under an abridged procedure (e.g., World Health Organization (WHO). Under Article 82(1) of Regulation (EC) No.
SQA
DECEMBER 16, 2022
ANVISA announced major updates to its Resolution of the Collegiate Board of Directors (RDC) 185/2001. China’s Center for Medical Device Evaluation (CMDE) Update Compliance Guidelines and Recommended Paths for Clinical Evaluation Paths for Certain Medical Devices, 25 July 2022. China: National Medical Products Administration (NMPA).
Expert insights. Personalized for you.
52 
Let's personalize your content